Expert Practice in Chronic Lymphocytic Leukemia: A Deep Dive Into the Disease
WebcastFaculty
OVERVIEW
Expert Practice in Chronic Lymphocytic Leukemia: A Deep Dive Into the Disease is organized by prIME oncology and will be held during May 31, 2017 - May 31, 2018. The target audience for this medical event is intended for medical oncologists, hematologists and other healthcare professionals involved in the management of CLL.
Strengthen your knowledge of chronic lymphocytic leukemia (CLL) with this in-depth, case-based expert faculty discussion. Initial discussion focuses on details of tumor biology and risk assessment. From there, interactive cases will highlight different patient groups followed by detailed examination of appropriate treatment options. Conventional therapy, new targeted options, and allogeneic stem cell transplantation will be reviewed along with in-depth discussion of the identification and appropriate management of adverse events observed in patients undergoing targeted treatment for CLL. Finally, we look to the future with new treatment options on the horizon.
Course Objective:
After successful completion of this educational activity, participants should be able to:
• Describe key features of CLL tumor biology and genomic heterogeneity
• Identify best practices for risk assessment and prognostication for patients with CLL
• Select optimal therapy for patients with newly diagnosed CLL
• Distinguish initial treatment options that are appropriate for frail or elderly patients with CLL
• Incorporate emerging therapies for management of relapsed/refractory CLL
• Identify patients who are likely to benefit from allogeneic stem cell transplantation
• Recognize key adverse events associated with available and novel therapies for CLL, as well as strategies to manage toxicity
Additional details will be posted as soon as they are available.
Strengthen your knowledge of chronic lymphocytic leukemia (CLL) with this in-depth, case-based expert faculty discussion. Initial discussion focuses on details of tumor biology and risk assessment. From there, interactive cases will highlight different patient groups followed by detailed examination of appropriate treatment options. Conventional therapy, new targeted options, and allogeneic stem cell transplantation will be reviewed along with in-depth discussion of the identification and appropriate management of adverse events observed in patients undergoing targeted treatment for CLL. Finally, we look to the future with new treatment options on the horizon.
Course Objective:
After successful completion of this educational activity, participants should be able to:
• Describe key features of CLL tumor biology and genomic heterogeneity
• Identify best practices for risk assessment and prognostication for patients with CLL
• Select optimal therapy for patients with newly diagnosed CLL
• Distinguish initial treatment options that are appropriate for frail or elderly patients with CLL
• Incorporate emerging therapies for management of relapsed/refractory CLL
• Identify patients who are likely to benefit from allogeneic stem cell transplantation
• Recognize key adverse events associated with available and novel therapies for CLL, as well as strategies to manage toxicity
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyHematology Blood and Marrow TransplantRELATED ONLINE COURSES
By eMedEd, Inc.
Aug 23, 2022 - Nov 30, 2026 | Webcast
State required course for New Jersey
3 AMA PRA Category 1 Credits™
...
...
By eMedEd, Inc.
May 25, 2022 - Nov 30, 2026 | Webcast
State required course for Connecticut ...
5 AMA PRA Category 1 Credits™
...
...
Quick Links